InspireMD Reports Third Quarter 2026 Financial Results

Received FDA approval of CGuard® Prime for Transcarotid Arterial Revascularization (TCAR) procedures, expected to approximately double the U.S. addressable market -- Company to host investor conference call today, November 12th, at 4:30pm ET -MIAMI, Nov. 12, 2026 (GLOBE NEWSWIRE) -- InspireMD, In…